Skip to Main Content

Paper Details

Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
Ann Surg Oncol
2
2022
CRC, ICI, PD-1, PD-1 ligand, PD-L1, Patients, SD, Stage 4 Colorectal Cancer, Tumors, colorectal cancer, metastatic CRC, mismatch repair, patient, patients, programmed cell death protein 1
Author NameAffiliation
Walid K ChatilaMemorial Sloan Kettering Cancer Center
Walid K ChatilaMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Walid K ChatilaMemorial Sloan Kettering Cancer Center
Mithat GonenMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
  • 1 - 10

Datasets

Release 1.2